Clinical Trials · NCT07225686

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy

Name: Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 3Maridebart cafraglutide

Phase: Phase 3
Recruitment status: Recruiting
Sponsor: Amgen
Enrollment: 250
Start date: Dec 2025
Locations: 60 sites, 11 countries
Primary endpoint: Change in AHI from baseline at week 52

View Maridebart-Cafraglutide compound reference